-
Symbol
-
SION on Nasdaq
-
Investment type
-
Equity / Common Stock, $0.001 par value per share
-
Latest Disclosed Ownership
-
2.48M shares
-
Security Ownership
-
5.6%
Shares, Excluding Options vs Price
Value, Excluding Options
Enavate Sciences GP, LLC ownership in Sionna Therapeutics, Inc. Common Stock, $0.001 par value per share (SION)
2025-02-18 - Enavate Sciences GP, LLC has filed an SCHEDULE 13D form with the Securities and Exchange Commission (SEC) disclosing ownership of 2.48M shares of Sionna Therapeutics, Inc. Common Stock, $0.001 par value per share (SION).
This represents 5.6% percent ownership of the company.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.